![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/095 | |
C07K 14/22 |
(11) | Number of the document | 3169357 |
(13) | Kind of document | T |
(96) | European patent application number | 15738352.2 |
Date of filing the European patent application | 2015-07-16 | |
(97) | Date of publication of the European application | 2017-05-24 |
(45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2015/066228 |
Date | 2015-07-16 |
(87) | Number | WO 2016/008960 |
Date | 2016-01-21 |
(30) | Number | Date | Country code |
14177564 | 2014-07-17 | EP |
(72) |
BOTTOMLEY, Matthew, IT
MASIGNANI, Vega, IT
|
(73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart Brussels,
BE
|
(54) | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES |
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES |